Paul J. Clancy, CFO at BIOGEN IDEC INC. (BIIB), sold 1,700 shares at $60.94 ($103K) on 2008-02-12, disclosed to the SEC on 2008-02-15.
Scheduled sale ($103k) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.56 | 742 | $45K | 43.5% |
| 2 | $60.76 | 200 | $12K | 11.8% |
| 3 | $60.82 | 58 | $4K | 3.4% |
| 4 | $60.88 | 200 | $12K | 11.8% |
| 5 | $60.94 | 200 | $12K | 11.8% |
| 6 | $60.99 | 100 |
| $6K |
| 5.9% |
| 7 | $61.25 | 100 | $6K | 5.9% |
| 8 | $61.29 | 100 | $6K | 5.9% |
| Total | $60.78 avg | 1,700 | $103K | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $1.4M | — | Filing → |
| BIIB | SELL | 2017-04-27 | $2.9M | — | Filing → |
| BIIB | SELL | 2017-03-14 | $5.8M | — | Filing → |